AI assistant
EXACT SCIENCES CORP — Director's Dealing 2017
Jul 31, 2017
30597_dirs_2017-07-31_e834e23d-32ba-4e14-9b97-bb2618605b66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-07-27
Reporting Person: WYZGA MICHAEL S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-27 | Common Stock | A | 791 | $0.00 | Acquired | 18376 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-27 | Deferred Stock Units | $0.00 | A | 5273 | Acquired | Common Stock (5273) | Direct |
Footnotes
F1: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.
F2: Represents deferred stock unit award issued pursuant to the Company's non-employee director compensation policy. Each deferred stock unit represents a contingent right to receive one share of common stock.
F3: These deferred stock units vest in full on the first anniversary of the grant date or, if earlier, the date of the next annual meeting of the Company's stockholders. Deferred stock units that become earned and vested are payable upon separation of service.